Inmune Bio, Inc. Quarterly Return On Assets in % from Q3 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Inmune Bio, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q3 2024.
  • Inmune Bio, Inc. Return On Assets for the quarter ending September 30, 2024 was -79 %, a 107% decline year-over-year.
  • Inmune Bio, Inc. annual Return On Assets for 2023 was -45.6 %, a 45.1% decline from 2022.
  • Inmune Bio, Inc. annual Return On Assets for 2022 was -31.4 %, a 13.5% increase from 2021.
  • Inmune Bio, Inc. annual Return On Assets for 2021 was -36.3 %, a 2.31% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -79 -40.9 -107% Jul 1, 2024 Sep 30, 2024
Q2 2024 -68.9 -34.6 -100% Apr 1, 2024 Jun 30, 2024
Q1 2024 -58.4 -25.5 -77.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -45.6 -14.2 -45.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -38.1 -4.04 -11.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -34.4 -0.66 -1.96% Apr 1, 2023 Jun 30, 2023
Q1 2023 -32.9 +3.15 +8.74% Jan 1, 2023 Mar 31, 2023
Q4 2022 -31.4 +4.91 +13.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -34 +0.7 +2.02% Jul 1, 2022 Sep 30, 2022
Q2 2022 -33.7 +2.7 +7.41% Apr 1, 2022 Jun 30, 2022
Q1 2022 -36.1 -2.21 -6.53% Jan 1, 2022 Mar 31, 2022
Q4 2021 -36.3 +0.86 +2.31% Oct 1, 2021 Dec 31, 2021
Q3 2021 -34.7 +4.6 +11.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -36.4 +3.17 +8.01% Apr 1, 2021 Jun 30, 2021
Q1 2021 -33.8 -2.79 -8.98% Jan 1, 2021 Mar 31, 2021
Q4 2020 -37.2 -6.77 -22.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -39.3 -8.51 -27.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -39.6 Apr 1, 2020 Jun 30, 2020
Q1 2020 -31.1 Jan 1, 2020 Mar 31, 2020
Q4 2019 -30.4 Oct 1, 2019 Dec 31, 2019
Q3 2019 -30.8 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.